173 related articles for article (PubMed ID: 30349302)
1. Effects of thyrotropin suppression on lumbar bone mineral density in postmenopausal women with differentiated thyroid carcinoma.
Zhang P; Xi H; Yan R
Onco Targets Ther; 2018; 11():6687-6692. PubMed ID: 30349302
[TBL] [Abstract][Full Text] [Related]
2. Effect of hypoparathyroid on bone mineral density of lumber spine in postmenopausal women with differentiated thyroid cancinoma.
Bai Y; Huo Y; Yu F; Wang D; Ma C
Hell J Nucl Med; 2017; 20 Suppl():7-13. PubMed ID: 29324909
[TBL] [Abstract][Full Text] [Related]
3. Effects of TSH suppressive therapy on bone mineral density (BMD) and bone turnover markers (BTMs) in patients with differentiated thyroid cancer in Northeast China: a prospective controlled cohort study.
Wang S; Wang Y; Zhu L; He L; Lv M; Zhang H; Wang H; Zhang F; Lai Y; Li Y; Shan Z; Teng W
Endocrine; 2023 Jan; 79(1):113-124. PubMed ID: 36089636
[TBL] [Abstract][Full Text] [Related]
4. Bone-density testing interval and transition to osteoporosis in differentiated thyroid carcinoma patients on TSH suppression therapy.
Park H; Park J; Yoo H; Kim S; Koh JH; Jee JH; Min YK; Chung JH; Kim TH; Kang M; Kim SW
Clin Endocrinol (Oxf); 2022 Jul; 97(1):130-136. PubMed ID: 35174522
[TBL] [Abstract][Full Text] [Related]
5. The effect of thyroid stimulating hormone suppressive therapy on bone geometry in the hip area of patients with differentiated thyroid carcinoma.
Moon JH; Jung KY; Kim KM; Choi SH; Lim S; Park YJ; Park DJ; Jang HC
Bone; 2016 Feb; 83():104-110. PubMed ID: 26518742
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.
Chen CH; Chen JF; Yang BY; Liu RT; Tung SC; Chien WY; Lu YC; Kuo MC; Hsieh CJ; Wang PW
J Formos Med Assoc; 2004 Jun; 103(6):442-7. PubMed ID: 15278189
[TBL] [Abstract][Full Text] [Related]
7. Measurements of Bone Health after Thyroid-Stimulating Suppression Therapy in Postmenopausal Women with Differentiated Thyroid Carcinoma: Bone Mineral Density versus the Trabecular Bone Score.
Chung CW; Choi HS; Kong SH; Park YJ; Park DJ; Ahn HY; Cho SW
J Clin Med; 2021 May; 10(9):. PubMed ID: 34063726
[TBL] [Abstract][Full Text] [Related]
8. The risk between thyrotropin suppression and bone mineral density in differentiated thyroid cancer.
Zou Y; Li B; Wang X; Mao J; Zhang Y
Medicine (Baltimore); 2022 Dec; 101(48):e31991. PubMed ID: 36482589
[TBL] [Abstract][Full Text] [Related]
9. The Effect of TSH Suppression on Vertebral Trabecular Bone Scores in Patients With Differentiated Thyroid Carcinoma.
Moon JH; Kim KM; Oh TJ; Choi SH; Lim S; Park YJ; Park DJ; Jang HC
J Clin Endocrinol Metab; 2017 Jan; 102(1):78-85. PubMed ID: 27754806
[TBL] [Abstract][Full Text] [Related]
10. Influence of Thyroid-stimulating Hormone Suppression Therapy on Bone Mineral Density in Patients with Differentiated Thyroid Cancer: A Meta-analysis.
Yoon BH; Lee Y; Oh HJ; Kim SH; Lee YK
J Bone Metab; 2019 Feb; 26(1):51-60. PubMed ID: 30899725
[TBL] [Abstract][Full Text] [Related]
11. Low trabecular bone score in postmenopausal women with differentiated thyroid carcinoma after long-term TSH suppressive therapy.
De Mingo Dominguez ML; Guadalix Iglesias S; Martin-Arriscado Arroba C; López Alvarez B; Martínez Diaz-Guerra G; Martinez-Pueyo JI; Ferrero Herrero E; Hawkins Carranza F
Endocrine; 2018 Oct; 62(1):166-173. PubMed ID: 30014437
[TBL] [Abstract][Full Text] [Related]
12. Effects of thyroid-stimulating hormone suppression after thyroidectomy for thyroid cancer on bone mineral density in postmenopausal women: a systematic review and meta-analysis.
Kwak D; Ha J; Won Y; Kwon Y; Park S
BMJ Open; 2021 May; 11(5):e043007. PubMed ID: 33986046
[TBL] [Abstract][Full Text] [Related]
13. Effect of thyrotropin suppressive therapy on lumbar bone mineral density in patients with differentiated thyroid cancer: a retrospective cohort study.
Wang X; Teng R; Liu F; Liu P; Yang Y
Gland Surg; 2022 Feb; 11(2):432-441. PubMed ID: 35284311
[TBL] [Abstract][Full Text] [Related]
14. Low BMI and low TSH value as risk factors related to lower bone mineral density in postmenospausal women under levothyroxine therapy for differentiated thyroid carcinoma.
de Melo TG; da Assumpção LV; Santos Ade O; Zantut-Wittmann DE
Thyroid Res; 2015; 8():7. PubMed ID: 26097507
[TBL] [Abstract][Full Text] [Related]
15. Trabecular bone score in women with differentiated thyroid cancer on long-term TSH-suppressive therapy.
Sousa BÉCA; Silva BC; de Oliveira Guidotti T; Pires MC; Soares MMS; Kakehasi AM
J Endocrinol Invest; 2021 Oct; 44(10):2295-2305. PubMed ID: 33730348
[TBL] [Abstract][Full Text] [Related]
16. Effect of TSH Suppression Therapy on Bone Mineral Density in Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis.
Ku EJ; Yoo WS; Lee EK; Ahn HY; Woo SH; Hong JH; Chung HK; Park JW
J Clin Endocrinol Metab; 2021 Nov; 106(12):3655-3667. PubMed ID: 34302730
[TBL] [Abstract][Full Text] [Related]
17. The effects of thyrotropin-suppressing therapy on bone metabolism in patients with well-differentiated thyroid carcinoma.
Kim MK; Yun KJ; Kim MH; Lim DJ; Kwon HS; Song KH; Kang MI; Baek KH
Bone; 2015 Feb; 71():101-5. PubMed ID: 25445448
[TBL] [Abstract][Full Text] [Related]
18. Volumetric bone mineral density and bone geometry assessed by peripheral quantitative computed tomography in women with differentiated thyroid cancer under TSH suppression.
Tournis S; Antoniou JD; Liakou CG; Christodoulou J; Papakitsou E; Galanos A; Makris K; Marketos H; Nikopoulou S; Tzavara I; Triantafyllopoulos IK; Dontas I; Papaioannou N; Lyritis GP; Alevizaki M
Clin Endocrinol (Oxf); 2015 Feb; 82(2):197-204. PubMed ID: 25040693
[TBL] [Abstract][Full Text] [Related]
19. Change of Bone Mineral Density and Biochemical Markers of Bone Turnover in Patients on Suppressive Levothyroxine Therapy for Differentiated Thyroid Carcinoma.
Kim CW; Hong S; Oh SH; Lee JJ; Han JY; Hong S; Kim SH; Nam M; Kim YS
J Bone Metab; 2015 Aug; 22(3):135-41. PubMed ID: 26389089
[TBL] [Abstract][Full Text] [Related]
20. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
